Symbol Name ID |
Ager
advanced glycosylation end product-specific receptor MGI:893592 |
Darker colors indicate more annotations |
Human Phenotypes | Decreased level of 1,5 anhydroglucitol in serum |
Increased LDL cholesterol concentration |
Hypercholesterolemia |
Hypertriglyceridemia |
Elevated circulating hepatic transaminase concentration |
Hyperglycemia |
Glucose intolerance |
Diabetes mellitus |
Type II diabetes mellitus |
Impaired glucose tolerance |
Insulin resistance |
Elevated sweat chloride |
Ketoacidosis |
Dehydration |
Fever |
Hypercalciuria |
Hematuria |
Pyuria |
Proteinuria |
Disease(s) Associated with AGER | |||||||||||||||||||
coronary artery disease | |||||||||||||||||||
cystic fibrosis | |||||||||||||||||||
systemic lupus erythematosus | |||||||||||||||||||
type 1 diabetes mellitus | |||||||||||||||||||
type 2 diabetes mellitus |
Mouse Phenotypes | abnormal vascular wound healing |
abnormal blood homeostasis |
increased circulating glucose level |
decreased circulating interleukin-6 level |
|
Availability | Mouse Genotype | ||||
Agertm1.1Arnd/Agertm1.1Arnd | |||||
Agertm1.1Hyam/Agertm1.1Hyam | |||||
Tg(Tagln-Ager)#Yon/? |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/16/2024 MGI 6.23 |
|
|